Daniel Sztankovics

4 Nagyvarad Ter
Budapest, BU 1089, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

EZH2 overexpression is associated with aggressive behavior and promotes cell proliferation in CNS WHO grade 3 meningiomas.

EZH2 overexpression is associated with aggressive behavior and promotes cell proliferation in CNS WHO grade 3 meningiomas.

Journal: Neuro-oncology advances

Published: July 28, 2025

Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma.

Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma.

Journal: International journal of molecular sciences

Published: May 21, 2025

Low-grade oncocytic tumor of the kidney-a clinical, pathological, and next generation sequencing-based study of 20 tumors.

Low-grade oncocytic tumor of the kidney-a clinical, pathological, and next generation sequencing-based study of 20 tumors.

Journal: Pathology oncology research : POR

Published: April 10, 2025

From 2D to 3D Bioprinted In Vitro Breast Cancer Model: A Comparative Study of Proliferation, Tissue Structure, and mTOR Signaling.

From 2D to 3D Bioprinted In Vitro Breast Cancer Model: A Comparative Study of Proliferation, Tissue Structure, and mTOR Signaling.

Journal: MedComm

Published: March 09, 2025

In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue Engineering.

In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue Engineering.

Journal: Bioengineering (Basel, Switzerland)

Published: January 09, 2025

Comparison of molecular subtype composition between independent sets of primary and brain metastatic small cell lung carcinoma and matched samples.

Comparison of molecular subtype composition between independent sets of primary and brain metastatic small cell lung carcinoma and matched samples.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 22, 2024

Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression.

Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression.

Journal: European journal of cell biology

Published: September 20, 2024

Rictor-A Mediator of Progression and Metastasis in Lung Cancer.

Rictor-A Mediator of Progression and Metastasis in Lung Cancer.

Journal: Cancers

Published: December 31, 2023

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies.

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies.

Journal: Pathology oncology research : POR

Published: December 15, 2023

RICTOR amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinoma.

RICTOR amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinoma.

Journal: Pathology oncology research : POR

Published: November 17, 2023

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas.

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas.

Journal: British journal of cancer

Published: August 10, 2023

Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing.

Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing.

Journal: Scientific reports

Published: July 29, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026